Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-12

Clinical Trial Update: Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining the effects of PEG, bisacodyl, and prucalopride on colonic motility in healthy subjects with chronic constipation completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisacodyl (bisacodyl)
  • PEG (polyethylene glycol)
  • PRUCALOPRIDE (Prucalopride)

Snippet

Sponsor: University Hospital, Gasthuisberg | Conditions: Chronic Constipation | Phase 4 | Status: COMPLETED